SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
82
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aaron’s, Inc. of Class Action Lawsuit and Upcoming Deadline – AAN

NEW YORK, March 14, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Aaron’s, Inc. (“Aaron’s” or the “Company”) (NYSE: AAN) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and indexed under 20-cv-01796, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired Aaron’s securities between March 2, 2018, and February 19, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Aaron’s securities during the class period, you have until April 28, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here for information about joining the class action]

Aaron’s was founded in 1955 and is headquartered in Atlanta, Georgia. The Company operates as an omnichannel provider of lease-purchase solutions to underserved and credit-challenged customers, and also engages in the sale, lease ownership, and specialty retailing of various products. 

Aaron’s operates in three reportable segments—Progressive Leasing (“Progressive”), Aaron’s Business (“AB”), and Vive Financial, LLC (“Vive”). The Progressive and AB segments are subject to federal regulatory agency oversight and scrutiny, including the Federal Trade Commission (“FTC”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose: (i) that Aaron’s had inadequate disclosure controls, procedures, and compliance measures; (ii) that, consequently, the operations of Aaron’s Progressive and AB segments were in violation of the FTC Act and/or relevant FTC regulations; (iii) that, consequently, Aaron’s earnings from those segments were partially derived from unlawful business practices and were thus unsustainable; (iv) the full extent of Aaron’s liability regarding the FTC’s investigation into its Progressive and AB segments, Aaron’s noncompliance with the FTC Act, and the likely negative consequences of all the foregoing on the Company’s financial results; and (v) that, as a result, the Company’s public statements were materially false and misleading at all relevant times.

On July 26, 2018, during after-market hours, Aaron’s filed a Quarterly Report on Form 10-Q with the Securities and Exchange Commission, reporting the Company’s financial and operating results for the fiscal quarter ended June 30, 2018. That Quarterly Report disclosed that, in July 2018, Aaron’s received civil investigative demands (“CIDs”) from the FTC requesting the production of documents and answers to written questions to determine whether disclosures related to financial products offered by the Company through its AB and Progressive segments were in violation of the FTC Act.

On this news, Aaron’s stock price fell $5.38 per share, or 11.01%, to close at $43.47 per share on July 27, 2018.

On April 25, 2019, during pre-market hours, Aaron’s filed another Quarterly Report on Form 10-Q with the SEC, reporting the Company’s financial and operating results for the fiscal quarter ended March 31, 2019. That Quarterly Report disclosed that, in April 2019, Aaron’s AB segment “received an unrelated CID from the FTC focused on certain transactions involving the purchase and sale of customer lease agreements, and whether such transactions violated the FTC Act.”

Then, on February 20, 2020, Aaron’s issued a press release announcing the Company’s financial results for the quarter and year ended December 31, 2019. Among other results, Aaron’s reported that the Company’s Progressive segment had reached an agreement in principle with FTC staff regarding the CID from the FTC that Progressive received in July 2018. Aaron’s advised investors that “[u]nder the proposed agreement, which requires final approval by FTC Commissioners and the U.S. District Court for the Northern District of Georgia, Progressive will make a payment of $175 million and enhance certain compliance-related activities, including monitoring, disclosure and reporting requirements.”

On this news, Aaron’s stock price fell $10.70 per share, or 19.06%, to close at $45.45 per share on February 20, 2020.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protalix to Reveal Q3 2026 Results Amid Rare Disease Push

Updated Category News Views 97

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

Continue Reading
Verra Mobility Welcomes New CEO with $4.75M Stock Grant

Updated Category News Views 45

New Crossroad for Verra Mobility Verra Mobility Corporation, the outfit making all those city intersection nightmares a bit more bearable, just rolled out the red carpet for Jon Newhard, their new head honcho. November 2, 2026, was the big day, but this isn’t just a pat on the back. We're talking a cushy entry with a one-off award that's not for chump change. Think of...

Continue Reading
Atomic Mobile's Global IoT Game Changer in Connectivity

Updated Category News Views 75

Atomic Orbit Unlocks Global Connectivity Think about the hassle businesses face globally when devices drop off the grid. It's like losing a lifeline. Atomic Mobile, outta Spring Lake, decided enough's enough and dropped their latest brainchild on the world — Atomic Orbit. This bad boy is turning heads because it's not clinging to a single carrier. Instead, it's dancing...

Continue Reading
Syra Health Hits Record Revenue, Sustains Growth

Updated Category News Views 89

Syra Health Reports Stellar Q3 Performance Folks, let's dive right into the figures: Syra Health's Q3 2026 performance is nothing short of a powerhouse display. We're talking about a jaw-dropping 52% surge in revenue compared to the same period last year, climbing to a record $2.6 million. It's not often you see a company swing its EPS from a loss of $(0.02) to a positive...

Continue Reading
Hospitals Face $392M Squeeze Under Medicare's CJR-X

Updated Category News Views 78

Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 105

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Hagerty Amplifies Profit Forecast Amid Premium Gains

Updated Category News Views 109

An Unyielding Growth Trajectory Hagerty, Inc. just unveiled its behemoth third quarter results for 2026 and they're nothing if not eye-popping. With a whopping 18% increase in written premium year-over-year to a towering $1,099 million, there's no mistaking Hagerty’s robust growth trajectory. And that's just one piece of the puzzle—earned premiums rocketed up by 42%...

Continue Reading
Orbital 2.0: A Game-Changer for Energy Operations

Updated Category News Views 47

Revolutionising Energy Systems with AI Some days, tech companies sling buzzwords like they're going out of style. But when Applied Computing dropped Orbital 2.0 at ADIPEC 2026, it seemed like there might be something solid behind the chatter. The updated AI system doesn't just crunch data—it learns the ins and outs of the actual processes keeping energy plants humming....

Continue Reading
Meiyume Unveils Futuristic Beauty Experience at Event

Updated Category News Views 63

Turning Heads in the World of Beauty Let's dive into the vibrant world of beauty innovation, where Meiyume's latest showcase at Cosmopack Asia 2026 has been the talk of the town. Located at Booth 3-C01, Meiyume introduced BEACON, a revolutionary experience that aims to guide brands in spotting market opportunities and realizing them through a connected global ecosystem....

Continue Reading
Markets Split on Election Day: Dow Dips, Nasdaq Soars

Updated Category News Views 25

Election Day rolled in like a wild card, with markets doing their dance that makes seasoned traders either groan or grin. This time, Tuesday saw the Dow slipping while the Nasdaq climbed higher, reflecting a split personality kind of session. Ain't it funny how one day can hold such different tales depending on which index gets your focus? Indices' Dance: Dow Down, Nasdaq...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Fiserv Class Action Lawsuit Details You Should Know

Updated Category News Views 150

Understanding the Fiserv Class Action Lawsuit Investors in Fiserv, Inc. have significant details to grasp concerning an ongoing class action lawsuit. This legal action runs the course of securities fraud allegations that have raised concerns among stakeholders. The importance of timely action cannot be overstated as investors look to protect their interests. Allegations...

Continue Reading
Market Trends Shift as Central Banks Keep Rates Steady

Updated Category News Views 84

Recent Changes in the Market Explained The financial world is undergoing some significant shifts following the latest actions taken by major central banks. Notably, the Fed's decisions have led to a clear change in how investors feel, causing the dollar to weaken against several currencies. Meanwhile, currencies linked to risk, like the Aussie and Kiwi, have gained...

Continue Reading
Royce Micro-Cap Trust Reports Performance Updates and Strategy

Updated Category News Views 183

Royce Micro-Cap Trust, Inc. (NYSE: RMT) was stirring things up back in the investment scene with an average weekly trading volume of about 469,790 shares. That kind of activity isn’t just noise; it indicates traders are keenly interested in how this closed-end diversified investment company handles its micro-cap portfolio. But here’s the kicker—while they’ve got...

Continue Reading
Tevogen Bio's Microsoft Collaboration Enhances HPV Treatment Strategy

Updated Category News Views 56

Tevogen Bio Leverages Advanced AI for HPV Treatment Development Tevogen Bio is making significant strides in the field of oncology with its pre-clinical efforts surrounding TVGN 920, marking a pivotal moment for the company as they embark on innovative cancer treatment pathways. By harnessing the power of artificial intelligence through a partnership with Microsoft,...

Continue Reading
STARLUX Airlines Boosts Cargo Operations with New A350F Freighters

Updated Category News Views 429

STARLUX Airlines Enhances Its Cargo Fleet STARLUX Airlines has taken a significant step by expanding its cargo fleet through the exercise of options for five additional A350F freighters. This strategic decision aims to double its freighter fleet, bringing the total to ten aircraft and establishing the airline as one of the leading purchasers of the A350F model in the...

Continue Reading